Bavarian Nordic

Danish vaccine manufacturing company

BAVA Nasdaq Copenhagen · home listing BVNRY OTC Markets Group ISIN DK0015998017 LEI 2138006JCDVYIN6INP51
Follow Bavarian Nordic Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2026 DKK · IFRS
Revenue, last year DKK 6.2B
Net income DKK 1.4B
EPS, diluted DKK 17.60
Operating cash flow DKK 2.7B
Revenue by fiscal year
DKK 5.7B
DKK 6.2B
FY24 FY26

Source: ESEF annual reports · latest filing